# An Open-Label and Long-Term Extension Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Patients With Ichthyoses

> **NCT04549792** · EARLY_PHASE1 · COMPLETED · sponsor: **Northwestern University** · enrollment: 13 (actual)

## Conditions studied

- Ichthyosis

## Interventions

- **DRUG:** Ustekinumab

## Key facts

- **NCT ID:** NCT04549792
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-01
- **Primary completion:** 2024-01-12
- **Final completion:** 2024-06-26
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2025-02-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04549792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04549792, "An Open-Label and Long-Term Extension Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Patients With Ichthyoses". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04549792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*